Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

O'Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW.

J Immunol. 2009 Mar 1;182(5):3202-12. doi: 10.4049/jimmunol.0802722.

2.

Identification and comparison of electrical tapes using instrumental and statistical techniques: II. Organic composition of the tape backing and adhesive.

Goodpaster JV, Sturdevant AB, Andrews KL, Briley EM, Brun-Conti L.

J Forensic Sci. 2009 Mar;54(2):328-38. doi: 10.1111/j.1556-4029.2008.00969.x. Epub 2009 Jan 31.

PMID:
19187453
3.
4.

Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord.

Hohmann AG, Briley EM, Herkenham M.

Brain Res. 1999 Mar 20;822(1-2):17-25.

PMID:
10082879
5.

LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M.

J Pharmacol Exp Ther. 1998 Jan;284(1):291-7.

6.

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW.

FEBS Lett. 1996 Sep 16;393(2-3):231-5.

7.

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL.

Mol Pharmacol. 1995 Sep;48(3):443-50.

PMID:
7565624
8.

Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC.

Mol Pharmacol. 1995 Aug;48(2):288-92.

PMID:
7651362
9.

Vasopressin Vla receptor-stimulated phospholipase D: differential regulation of transphosphatidylation and phospholipid hydrolysis by protein kinase C [corrected].

Garces Y, Briley EM, Felder CC.

Neuropeptides. 1995 May;28(5):277-85. Erratum in: Neuropeptides 1995 Aug;29(2):101.

PMID:
7603588
11.
12.

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.

Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA.

Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7656-60.

13.

Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.

Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA.

Mol Pharmacol. 1992 Nov;42(5):838-45. Erratum in: Mol Pharmacol 1994 Aug;46(2):397.

PMID:
1331766
14.

Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.

Kanterman RY, Mahan LC, Briley EM, Monsma FJ Jr, Sibley DR, Axelrod J, Felder CC.

Mol Pharmacol. 1991 Mar;39(3):364-9.

PMID:
1848657
15.

Muscarinic receptors mediate the release of arachidonic acid from spinal cord and hippocampal neurons in primary culture.

Kanterman RY, Ma AL, Briley EM, Axelrod J, Felder CC.

Neurosci Lett. 1990 Oct 16;118(2):235-7.

PMID:
2125713

Supplemental Content

Loading ...
Support Center